trending Market Intelligence /marketintelligence/en/news-insights/trending/qjabpjae-roz1kemaagzlw2 content esgSubNav
In This List

Essa Pharma regains Nasdaq compliance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Essa Pharma regains Nasdaq compliance

Essa Pharma Inc. regained compliance with the Nasdaq Stock Market's minimum market value listing requirement.

The Canadian pharmaceutical company recently completed a reverse stock split to meet Nasdaq's $1 minimum required bid price.